Information updates

Bayer Novalac Allergy Infant Formula Update

Due to supply challenges, Bayer is expecting temporary out of stock of Novalac Allergy Infant Formula in pharmacies across Australia, with normal supply resuming late March to early April. Limited availability may continue in April in some pharmacies across Australia as stock levels rebuild. Other products in the Novalac range are not suitable for infants with cow’s milk protein allergy.

As the distributor of Novalac Allergy, Bayer is working closely with the global manufacturer to improve supply and apologise for this disruption, particularly as babies who are fed Novalac Allergy Infant Formula are vulnerable patients with specialised nutrition requirements.

Parents and carers are encouraged to contact their local pharmacy to check stock levels before going in-store. If they are unable to find Novalac Allergy in pharmacies, it is recommended that they speak to their healthcare professional who can provide medical advice about alternative products specifically for their baby, which are listed on the ASCIA website www.allergy.org.au/hp/papers/guide-for-milk-substitutes-cows-milk-allergy

Contact Bayer’s Medical Information Team on1800 008 757 or This email address is being protected from spambots. You need JavaScript enabled to view it. should you have any questions.

 

This news item was issued on 24 March 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.  

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.